PDT Partners LLC Takes Position in Walgreens Boots Alliance, Inc. $WBA

Key Points

• PDT Partners LLC has purchased 170,622 shares of Walgreens Boots Alliance, Inc., valued at approximately $1,906,000, marking a significant new stake in the company.
• Institutional ownership stands at 58.59%, with several hedge funds recently adjusting their positions, indicating ongoing interest from institutional investors.
• Walgreens Boots Alliance reported $0.38 EPS for the last quarter, surpassing estimates and showing a revenue growth of 7.2% year-over-year, with a consensus rating of "Reduce" from analysts.

PDT Partners LLC bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 170,622 shares of the pharmacy operator's stock, valued at approximately $1,906,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Curat Global LLC acquired a new position in shares of Walgreens Boots Alliance in the 1st quarter worth approximately $27,000. Sentry Investment Management LLC acquired a new position in Walgreens Boots Alliance during the 1st quarter worth $27,000. Colonial Trust Co SC lifted its holdings in Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,297 shares in the last quarter. Federated Hermes Inc. lifted its holdings in Walgreens Boots Alliance by 135.8% during the 1st quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock worth $35,000 after buying an additional 1,815 shares in the last quarter. Finally, N.E.W. Advisory Services LLC acquired a new position in Walgreens Boots Alliance during the 1st quarter worth $43,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

WBA has been the topic of several research reports. UBS Group reaffirmed a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They set a "hold" rating on the stock. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. One analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Walgreens Boots Alliance has an average rating of "Reduce" and a consensus price target of $10.15.

Walgreens Boots Alliance Stock Performance

WBA stock remained flat at $11.98 during trading hours on Friday. The firm's fifty day moving average is $11.75 and its 200-day moving average is $11.31. The stock has a market cap of $10.37 billion, a price-to-earnings ratio of -1.64, a P/E/G ratio of 1.42 and a beta of 0.80. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. The firm had revenue of $38.99 billion during the quarter, compared to analysts' expectations of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%.The company's revenue was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.63 EPS. As a group, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.